US Stock MarketDetailed Quotes
OLMA Olema Pharmaceuticals
- 8.780
- +0.910+11.56%
Close Nov 22 16:00 ET
- 8.780
- 0.0000.00%
Post 20:02 ET
503.08MMarket Cap-3850P/E (TTM)
8.900High7.910Low1.21MVolume8.210Open7.870Pre Close10.38MTurnover4.18%Turnover RatioLossP/E (Static)57.30MShares16.77552wk High2.53P/B253.15MFloat Cap7.67552wk Low--Dividend TTM28.83MShs Float60.270Historical High--Div YieldTTM12.58%Amplitude2.000Historical Low8.605Avg Price1Lot Size
Olema Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 61.17%37.62M | 55.22%33.53M | 16.00%34.34M | -1.89%104.96M | 11.75%30.42M | 0.52%23.34M | -35.12%21.6M | 27.30%29.6M | 49.65%106.99M | 25.10%27.22M |
| Selling and administrative expenses | 13.01%4.4M | 22.40%4.42M | -34.24%4.46M | -23.84%18.82M | -19.36%4.54M | -30.49%3.89M | -42.11%3.61M | -6.47%6.78M | 21.20%24.71M | -2.54%5.64M |
| -General and administrative expense | 13.01%4.4M | 22.40%4.42M | -34.24%4.46M | -23.84%18.82M | -19.36%4.54M | -30.49%3.89M | -42.11%3.61M | -6.47%6.78M | 21.20%24.71M | -2.54%5.64M |
| Research and development costs | 70.80%33.23M | 61.82%29.11M | 30.92%29.88M | 4.70%86.14M | 19.87%25.87M | 10.36%19.45M | -33.51%17.99M | 42.58%22.83M | 61.01%82.27M | 35.11%21.58M |
| Operating profit | -61.17%-37.62M | -55.22%-33.53M | -16.00%-34.34M | 1.89%-104.96M | -11.75%-30.42M | -0.52%-23.34M | 35.12%-21.6M | -27.30%-29.6M | -49.65%-106.99M | -25.10%-27.22M |
| Net non-operating interest income expense | 52.58%2.93M | 100.52%3.11M | 156.86%3.35M | 273.65%8.33M | 264.95%3.55M | 208.52%1.92M | 273.49%1.55M | 498.62%1.31M | 404.07%2.23M | 792.66%973K |
| Non-operating interest income | 52.58%2.93M | 100.52%3.11M | 156.86%3.35M | 273.65%8.33M | 264.95%3.55M | 208.52%1.92M | 273.49%1.55M | 498.62%1.31M | 404.07%2.23M | 792.66%973K |
| Other net income (expense) | 274.68%138K | 190.91%40K | 54.55%17K | 29.63%-19K | 38.81%93K | 34.17%-79K | -320.00%-44K | 83.33%11K | 42.55%-27K | 570.00%67K |
| Other non- operating income (expenses) | 274.68%138K | 190.91%40K | 54.55%17K | 29.63%-19K | 38.81%93K | 34.17%-79K | -320.00%-44K | 83.33%11K | 42.55%-27K | 570.00%67K |
| Income before tax | -60.71%-34.56M | -51.19%-30.38M | -9.49%-30.97M | 7.76%-96.66M | -2.27%-26.77M | 5.36%-21.5M | 38.84%-20.1M | -22.82%-28.29M | -47.39%-104.79M | -20.99%-26.18M |
| Income tax | ||||||||||
| Net income | -60.71%-34.56M | -51.19%-30.38M | -9.49%-30.97M | 7.76%-96.66M | -2.27%-26.77M | 5.36%-21.5M | 38.84%-20.1M | -22.82%-28.29M | -47.39%-104.79M | -20.99%-26.18M |
| Net income continuous Operations | -60.71%-34.56M | -51.19%-30.38M | -9.49%-30.97M | 7.76%-96.66M | -2.27%-26.77M | 5.36%-21.5M | 38.84%-20.1M | -22.82%-28.29M | -47.39%-104.79M | -20.99%-26.18M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -60.71%-34.56M | -51.19%-30.38M | -9.49%-30.97M | 7.76%-96.66M | -2.27%-26.77M | 5.36%-21.5M | 38.84%-20.1M | -22.82%-28.29M | -47.39%-104.79M | -20.99%-26.18M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -60.71%-34.56M | -51.19%-30.38M | -9.49%-30.97M | 7.76%-96.66M | -2.27%-26.77M | 5.36%-21.5M | 38.84%-20.1M | -22.82%-28.29M | -47.39%-104.79M | -20.99%-26.18M |
| Basic earnings per share | -25.00%-0.6 | -10.20%-0.54 | 20.00%-0.56 | 18.32%-2.14 | 26.15%-0.48 | 15.79%-0.48 | 40.24%-0.49 | -20.69%-0.7 | -45.56%-2.62 | -20.37%-0.65 |
| Diluted earnings per share | -25.00%-0.6 | -10.20%-0.54 | 20.00%-0.56 | 18.32%-2.14 | 26.15%-0.48 | 15.79%-0.48 | 40.24%-0.49 | -20.69%-0.7 | -45.56%-2.62 | -20.37%-0.65 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
